Somatostatin and chemokine CXCR4 receptor expression in pancreatic adenocarcinoma relative to pancreatic neuroendocrine tumours.

Ylberta KajtaziDaniel KaemmererJörg SängerStefan SchulzAmelie Lupp

Published in: Journal of cancer research and clinical oncology (2019)

SST or CXCR4 expression in PAC is clearly of no therapeutic relevance. However, indirect targeting of these tumours via SST3, SST5, or CXCR4 on tumour microvessels may represent a promising additional therapeutic strategy.

Keyphrases

cell migration
poor prognosis
binding protein
long non coding rna
neuroendocrine tumors
drug delivery